Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer

about

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

P2860

Q24239985-291AADD7-B63D-4E8F-818D-A85AE13E1020 Q24246391-368A440E-AF50-4933-A6A3-21A67E238F89 Q36081653-FEE34DFC-7CA0-4756-87A6-908B64DC6599

P2860

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer

Item

http://www.wikidata.org/entity/Q36079441

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Endocrinological and clinical ...... tane in advanced breast cancer

@ast

Endocrinological and clinical ...... tane in advanced breast cancer

@en

type

Item

label

Endocrinological and clinical ...... tane in advanced breast cancer

@ast

Endocrinological and clinical ...... tane in advanced breast cancer

@en

prefLabel

Endocrinological and clinical ...... tane in advanced breast cancer

@ast

Endocrinological and clinical ...... tane in advanced breast cancer

@en

P1476

Endocrinological and clinical ...... tane in advanced breast cancer

@en

P2093

C Bartoli

http://www.w3.org/2001/XMLSchema#string

C Noberasco

http://www.w3.org/2001/XMLSchema#string

D Moglia

http://www.w3.org/2001/XMLSchema#string

E Bajetta

http://www.w3.org/2001/XMLSchema#string

M Merson

http://www.w3.org/2001/XMLSchema#string

N Zilembo

http://www.w3.org/2001/XMLSchema#string

R Buzzoni

http://www.w3.org/2001/XMLSchema#string

V Sacchini

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.

Towards a molecular basis for tamoxifen resistance in breast cancer.

Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.

4-hydroxyandrostenedione--further clinical and extended endocrine observations.

Assessment of response to therapy in advanced breast cancer.

Clinical use of aromatase inhibitors in human breast carcinoma.

Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.

Endocrine treatment of breast cancer in women.

Aromatase inhibitors and hormone-dependent cancers.

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

P2888

bjc.1994.265

P304

145-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1994.265

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luigi Celio

Angelo Di Leo

P577

1994-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15179772

http://www.w3.org/2001/XMLSchema#string

P698

8018527

http://www.w3.org/2001/XMLSchema#string

P932

2033308

http://www.w3.org/2001/XMLSchema#string

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer

about

P2860

P2860

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932